Avantor's CEO acknowledged high competitive intensity, while CFO emphasized margin pressures and Ligner prepared to take over as CEO.
5 reports, 2 independent
Updated Aug 13
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Avantor's CEO acknowledged high competitive intensity, while CFO emphasized margin pressures and Ligner prepared to take over as CEO.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Avantor faces high competitive intensity and margin pressures as Ligner prepares for CEO transition.1 source
Ligner assumes CEO role at Avantor; GS and Paul Weiss serve as advisors.1 source
Keep exploring
The entities involved
-
Avantor
U.S. chemical company
Coverage
Newest first; wire copies grouped- StockStoryAVTR Q2 Deep Dive: Margin Pressures Mount as Competitive Intensity Rises and Leadership Transition Looms Life sciences company Avantor (NYSE:AVTR) reported Q2 CY2025 results topping the market’s reve
- PR NewswireAvantor® Reiterates Shareholder Value Creation Focus Emmanuel Ligner, Seasoned Leader with Proven Track Record of Value Creation in Life Sciences, to Begin Role as CEO Next Week RADNOR, Pa., Aug. 11,
- StockStoryWhy Avantor (AVTR) Shares Are Plunging Today Shares of life sciences company Avantor (NYSE:AVTR) fell 15.5% in the morning session after the company reported disappointing second-quarter results and
- StockStoryWhy Avantor (AVTR) Shares Are Trading Lower Today Shares of life sciences company Avantor (NYSE:AVTR) fell 8% in the afternoon session after the company announced that it has appointed Emmanuel Ligne
- PR NewswireAvantor Announces Emmanuel Ligner as Next President and CEO Seasoned Executive with Proven Track Record of Value Creation in Life Sciences RADNOR, Pa., July 21, 2025 /PRNewswire/ -- Avantor, Inc. (NY